Anzeige
Meldung des Tages: Rüstungsindustrie unter Druck: Warum ein seltenes Metall plötzlich zum Milliardenfaktor wird

Oramed Pharmaceuticals News

Aktie
WKN:  A1CTNU ISIN:  US68403P2039 US-Symbol:  ORMP Branche:  Biotechnologie Land:  USA
3,33 $
+0,07 $
+2,15%
2,8685 € 20:26:13 Uhr
Depot/Watchlist
Marktkapitalisierung *
102,37 Mio. €
Streubesitz
68,19%
KGV
2,18
Dividende
0,25 $
Dividendenrendite
7,79%
Index-Zuordnung
-

Oramed Pharmaceuticals News

13.01.26 - PR Newswire
Oramed and Lifeward Announce Strategic Transaction
Oramed and Lifeward Announce Strategic Transaction PR Newswire
07.01.26 - PR Newswire
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments PR Newswire
17.11.25 - PR Newswire
Oramed Reports Fiscal Third Quarter 2025 Financial Results
Oramed Reports Fiscal Third Quarter 2025 Financial Results PR Newswire
17.11.25 - PR Newswire
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS PR Newswire
10.11.25 - inv3st.de
Patientenwohl als Schlüssel zu Rendite: Oramed Pharmaceutials, Roche, BioNxt
Höher, schneller, weiter - nicht nur im Sport kommt es auf ständigen Fortschritt an. Auch in Wirtschaft und Wissenschaft geht es um stete Innovationen und Verbesserungen. Die ...
23.10.25 - PR Newswire
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives PR Newswire
28.04.25 - PR Newswire
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical PR Newswire
04.03.25 - PR Newswire
Oramed Pharmaceuticals Issues Letter to Shareholders
Oramed Pharmaceuticals Issues Letter to Shareholders PR Newswire
11.02.25 - PR Newswire
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin PR Newswire
09.11.24 - Börse-Global
Oramed Aktie: Verlässlichkeit bleibt priorisiert
Oramed Pharmaceuticals Inc. hat kürzlich die Ergebnisse für das dritte Quartal und die ersten neun Monate des Jahres 2024 veröffentlicht. Das Unternehmen, das sich auf die ...
07.10.24 - PR Newswire
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt PR Newswire
26.06.24 - PR Newswire
Oramed Letter to Shareholders
Oramed Letter to Shareholders PR Newswire
26.06.24 - PR Newswire
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock PR Newswire
20.02.24 - PR Newswire
Oramed Letter to Shareholders
Oramed Letter to Shareholders PR Newswire
22.09.23 - PR Newswire
Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company
Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that ...
22.09.23 - PR Newswire
Thinking about buying stock in MicroAlgo, Oramed Pharmaceuticals, Limbach Holdings, Niu Technologies, or Applied Molecular Transport?
Thinking about buying stock in MicroAlgo, Oramed Pharmaceuticals, Limbach Holdings, Niu Technologies, or Applied Molecular Transport? PR Newswire
21.09.23 - PR Newswire
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company
Oramed Announces $101,875,000 Short-​Term Senior Secured Note Transaction with Scilex Holding Company PR Newswire
02.08.23 - PR Newswire
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally PR Newswire
20.06.23 - PR Newswire
Oramed to Present at the 83rd American Diabetes Association Conference
Oramed to Present at the 83rd American Diabetes Association Conference PR Newswire
18.05.23 - PR Newswire
Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit
Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit PR Newswire

Newssuche

Videos

newspaper
10:40 Uhr +38,58%
Technical Trading: DAX Long Chance
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »